NCT05792865 is a clinical trial of paxlovid in COVID-19, sponsored by Beijing Chao Yang Hospital.

Who is sponsoring NCT05792865?

NCT05792865 is sponsored by Beijing Chao Yang Hospital.

What drugs are being tested in NCT05792865?

Interventions in NCT05792865: paxlovid, No paxlovid, Paxlovid.

Is NCT05792865 still recruiting?

NCT05792865 is currently status unknown. Last updated 31 March 2023.

Last reviewed 2023-03-31 · How we verify

NCT05792865

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Registry Study of Patients Hospitalized With Confirmed COVID-19

Status unknown Last updated 31 March 2023

What this trial tests

trial testing paxlovid in COVID-19 in 488 participants. Status unknown.

Timeline

30 March 2023

Primary endpoint
30 June 2023

30 December 2023

Quick facts

Lead sponsor	Beijing Chao Yang Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	488
Start date	30 March 2023
Primary completion	30 June 2023
Estimated completion	30 December 2023

Drugs / interventions tested

paxlovid (paxlovid) — full drug profile →
No paxlovid — full drug profile →
Paxlovid (paxlovid) — full drug profile →

Conditions studied

COVID-19 — all drugs for COVID-19 →

Sponsor

Beijing Chao Yang Hospital

Who can join

18 and older, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The design of this registered study aims to evaluate the efficacy and safety of Paxlovid in the treatment of hospitalized COVID-19 patients, and to explore factors related to the efficacy and safety of Paxlovid.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak.
Wang X, Zhang Y, Huang C, Yang H, et al · · 2024 · cited 4× · PMID 38904423 · DOI 10.1080/21645515.2024.2361500
Nirmatrelvir-Ritonavir Reduced Mortality in Hospitalized Patients with COVID-19 During the Omicron Outbreak: Real-World Evidence from Beijing.
Zhang Y, Wang X, Huang C, Yang H, et al · · 2024 · cited 3× · PMID 38618583 · DOI 10.2147/idr.s445826
COVID-19 multi-omics reveal organ-specific responses and biomarkers.
Ding X, Lu Q, Hu T, Zhang Y, et al · · 2026 · PMID 41578334 · DOI 10.1186/s12967-025-07459-2

Verify or expand the search:

Other trials of paxlovid

Trials testing the same drug.

NCT05682586 — UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients · Phase 3 · unknown

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other Beijing Chao Yang Hospital trials

Trials by the same sponsor.

NCT07520305 — Efficacy Heterogeneity of Lactobacillus Paracasei LC19 on Type 2 Diabetes · NA · not yet recruiting
NCT07490925 — Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDS · NA · not yet recruiting
NCT07382986 — IMPACT COPD Cohort (China) · recruiting
NCT07323134 — The Effect of Semaglutide on the Intestinal Flora in Obesity · not yet recruiting
NCT07049692 — Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05792865 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beijing Chao Yang Hospital
Last refreshed: 31 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05792865.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing